Abstract
We sequenced 1500-bp genomic DNA regions upstream from the survivin gene (BIRC5). DNA was isolated from human placenta and tumors of patients with diagnosed squamous cancer of the lung that showed high-level BIRC5 gene expression. We have revealed four new promoter allelic variants differing in single nucleotide substitutions, one variant with two nucleotide substitutions, and a variant with a TAAA tetranucleotide insertion. All promoter variants displayed low activity in cells with functionally active p53 protein and high activity in cell lines characterized by low level or absence of p53 protein function. The activity of the promoters with single nucleotide substitutions was comparable to that of the wild-type promoter, whereas two nucleotide substitutions markedly reduced the activity. We also demonstrated the functional significance of a putative Sp1 transcription factor-binding site at (−63...−54) upstream from the transcription initiation site. Mutation within this sequence led to a sharp decrease of promoter activity. The functional architecture of the survivin promoter is discussed based on results known from the literature and those obtained here.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- BIRC5 :
-
survivin gene
- CDE:
-
cell cycle-dependent element
- SNP:
-
single nucleotide polymorphism
References
Henson, P. M., and Hume, D. A. (2006) Trends Immunol., 27, 244–250.
Jacobson, M. D., Weil, M., and Raff, M. C. (1997) Cell, 88, 347–354.
Vermeulen, K., van Bockstaele, D. R., and Berneman, Z. N. (2005) Ann. Hematol., 84, 627–639.
Altieri, D. C. (2008) Nat. Rev. Cancer, 8, 61–70.
Ambrosini, G., Adida, C., and Altieri, D. C. (1997) Nat. Med., 3, 917–921.
Fukuda, S., and Pelus, L. M. (2006) Mol. Cancer Ther., 5, 1087–1098.
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., and Altieri, D. C. (1998) Nature, 396, 580–584.
Jiang, Y., Saavedra, H. I., Holloway, M. P., Leone, G., and Altura, R. A. (2004) J. Biol. Chem., 279, 40511–40520.
Raj, D., Liu, T., Samadashwily, G., Li, F., and Grossman, D. (2008) Carcinogenesis, 29, 194–201.
Wagner, M., Schmelz, K., Dorken, B., and Tamm, I. (2008) Int. J. Cancer, 122, 1278–1287.
Cosgrave, N., Hill, A. D., and Young, L. S. (2006) J. Mol. Endocrinol., 37, 377–390.
Li, F., and Altieri, D. C. (1999) Biochem. J., 344,Pt. 2, 305–311.
Xu, R., Zhang, P., Huang, J., Ge, S., Lu, J., and Qian, G. (2007) Biochem. Biophys. Res. Commun., 356, 286–292.
Zhu, N., Gu, L., Findley, H. W., Chen, C., Dong, J. T., Yang, L., and Zhou, M. (2006) J. Biol. Chem., 281, 14711–14718.
Li, Y., Xie, M., Yang, J., Yang, D., Deng, R., Wan, Y., and Yan, B. (2006) Oncogene, 25, 3296–3306.
Peng, X. H., Karna, P., Cao, Z., Jiang, B. H., Zhou, M., and Yang, L. (2006) J. Biol. Chem., 281, 25903–25914.
Esteve, P. O., Chin, H. G., and Pradhan, S. (2007) J. Biol. Chem., 282, 2615–2625.
Grossman, D., Kim, P. J., Blanc-Brude, O. P., Brash, D. E., Tognin, S., Marchisio, P. C., and Altieri, D. C. (2001) J. Clin. Invest., 108, 991–999.
Mirza, A., McGuirk, M., Hockenberry, T. N., Wu, Q., Ashar, H., Black, S., Wen, S. F., Wang, L., Kirschmeier, P., Bishop, W. R., Nielsen, L. L., Pickett, C. B., and Liu, S. (2002) Oncogene, 21, 2613–2622.
Briggs, M. R., Kadonaga, J. T., Bell, S. P., and Tjian, R. (1986) Science, 234, 47–52.
Jang, J. S., Kim, K. M., Kang, K. H., Choi, J. E., Lee, W. K., Kim, C. H., Kang, Y. M., Kam, S., Kim, I. S., Jun, J. E., Jung, T. H., and Park, J. Y. (2008) Lung Cancer, 60, 31–39.
Xu, Y., Fang, F., Ludewig, G., Jones, G., and Jones, D. (2004) DNA Cell Biol., 23, 527–537.
Borbely, A. A., Murvai, M., Szarka, K., Konya, J., Gergely, L., Hernadi, Z., and Veress, G. (2007) J. Clin. Pathol., 60, 303–306.
Wagner, M., Schmelz, K., Dorken, B., and Tamm, I. (2008) Leuk. Res., 32, 1054–1060.
Hattori, M., Sakamoto, H., Satoh, K., and Yamamoto, T. (2001) Cancer Lett., 169, 155–164.
Adams, R. L. P. (1980) Cell Culture for Biochemists, Elsevier/North-Holland Biomedical Press, Amsterdam-New York.
Mashima, T., Oh-hara, T., Sato, S., Mochizuki, M., Sugimoto, Y., Yamazaki, K., Hamada, J., Tada, M., Moriuchi, T., Ishikawa, Y., Kato, Y., Tomoda, H., Yamori, T., and Tsuruo, T. (2005) J. Natl. Cancer Inst., 97, 765–777.
Nicholson, S. A., Okby, N. T., Khan, M. A., Welsh, J. A., McMenamin, M. G., Travis, W. D., Jett, J. R., Tazelaar, H. D., Trastek, V., Pairolero, P. C., Corn, P. G., Herman, J. G., Liotta, L. A., Caporaso, N. E., and Harris, C. C. (2001) Cancer Res., 61, 5636–5643.
Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. (1991) Proc. Natl. Acad. Sci. USA, 88, 5523–5527.
Chen, J. Y., Funk, W. D., Wright, W. E., Shay, J. W., and Minna, J. D. (1993) Oncogene, 8, 2159–2166.
Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R., and Altieri, D. C. (2003) Lancet, 362, 205–209.
Ghaleb, A. M., Nandan, M. O., Chanchevalap, S., Dalton, W. B., Hisamuddin, I. M., and Yang, V. W. (2005) Cell Res., 15, 92–96.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M. V. Mityaev, E. P. Kopantzev, A. A. Buzdin, T. V. Vinogradova, E. D. Sverdlov, 2008, published in Biokhimiya, 2008, Vol. 73, No. 11, pp. 1476–1485.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM08-160, October 12, 2008.
Rights and permissions
About this article
Cite this article
Mityaev, M.V., Kopantzev, E.P., Buzdin, A.A. et al. Functional significance of a putative Sp1 transcription factor binding site in the survivin gene promoter. Biochemistry Moscow 73, 1183–1191 (2008). https://doi.org/10.1134/S0006297908110035
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297908110035